Assessment of Limb Perfusion During Junctional Tourniquet
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this study is to use contrast enhanced ultrasound to determine the degree to which flow is reduced during application of a junctional tourniquet (JT). Contrast enhanced ultrasound is performed to quantify thigh and calf perfusion at baseline and during application of the JT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Posted
Study publicly available on registry
March 20, 2014
CompletedResults Posted
Study results publicly available
May 29, 2015
CompletedMay 29, 2015
May 1, 2015
6 months
January 6, 2014
April 22, 2015
May 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle Perfusion
Contrast ultrasound perfusion imaging will be performed at baseline and 1 min after application of the JT.
baseline and 1 min post occlusion
Study Arms (1)
Normal subjects
EXPERIMENTALNormal subjects, all of whom undergo brief application of junctional tourniquet
Interventions
All subjects will be studied at baseline and after placement of a junctional tourniquet to the femoral artery.
Eligibility Criteria
You may qualify if:
- Healthy subject
- Age 19-50
You may not qualify if:
- Peripheral artery disease
- Known heart failure
- Right to left shunt
- Pregnancy
- Presence of femoral artery aneurysm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OHSU
Portland, Oregon, 97239, United States
Related Publications (1)
Davidson BP, Belcik JT, Mott BH, Landry G, Lindner JR. Quantification of residual limb skeletal muscle perfusion with contrast-enhanced ultrasound during application of a focal junctional tourniquet. J Vasc Surg. 2016 Jan;63(1):148-53. doi: 10.1016/j.jvs.2014.06.107. Epub 2014 Jul 24.
PMID: 25065582DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jonathan Lindner MD
- Organization
- Oregon Health & Science University
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan R Lindner, MD
Oregon Health and Science University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 6, 2014
First Posted
March 20, 2014
Study Start
September 1, 2013
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
May 29, 2015
Results First Posted
May 29, 2015
Record last verified: 2015-05